Chr. Hansen continues strong momentum with 10% organic growth in Q2
…& Enzymes delivered 8% growth Underlying EBIT margin b.s.i.1) of 30.9%, incl. >1%-point negative currency impact, compared to 32.2% in Q2 2019/20. Reported EBIT margin b.s.i. (incl. all acquisition impacts)…